Last update 01 Nov 2024

MSD Korea Co. Ltd.

Subsidiary Company|
South Korea
|
www.msd-korea.com

Overview

Tags

Hemic and Lymphatic Diseases
Infectious Diseases
Other Diseases
Small molecule drug
Monoclonal antibody

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases5
Hemic and Lymphatic Diseases5
Immune System Diseases4
Endocrinology and Metabolic Disease4
Neoplasms4
Nervous System Diseases3
Top 5 Drug TypeCount
Small molecule drug6
Monoclonal antibody1
Top 5 TargetCount
CMV DNA terminase1
1,3-beta-glucan synthase1
PD-1(Programmed cell death protein 1)1
FGFR1 x FGFR2 x FGFR3 x FGFR4 x PDGFRα x RET x VEGFR1 x VEGFR2 x VEGFR3 x c-Kit1
HIF-2α(Endothelial PAS domain-containing protein 1)1

Related

7
Drugs associated with MSD Korea Co. Ltd.
Belzutifan
Target
HIF-2α
Mechanism
HIF-2α inhibitors
Active Org.
MSD R&D (China) Co. Ltd.MSD R&D (China) Co. Ltd. [+9]
Originator Org.
Merck Sharp & Dohme Corp.Merck Sharp & Dohme Corp.
Active Indication
Advanced Renal Cell Carcinoma [+24]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date13 Aug 2021
Doravirine/lamivudine/tenofovir disoproxil fumarate
Target
RT
Mechanism
RT inhibitors
Active Org.
Merck Sharp & Dohme BV [+4]
Originator Org.
Merck & Co., Inc.Merck & Co., Inc.
Active Indication
HIV Infections
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date30 Aug 2018
Ertugliflozin pidolate
Target
SGLT2
Mechanism
SGLT2 inhibitors
Active Org.
Merck Sharp & Dohme Corp.Merck Sharp & Dohme Corp. [+5]
Originator Org.
Pfizer Inc.Pfizer Inc.
Active Indication
Diabetes Mellitus, Type 2 [+7]
Inactive Indication
Chronic Kidney Diseases [+3]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date19 Dec 2017
7
Clinical Trials associated with MSD Korea Co. Ltd.
NCT05036434 / Enrolling by invitationPhase 2IIT
A Prospective Phase II Trial of Pembrolizumab Plus Lenvatinib in Advanced Adrenal Cortical Carcinoma After Failure of Platinum- and Mitotane-Based Chemotherapy
KCT0005125 / Not yet recruitingNot Applicable
Non-randomized clinical trial to compare the immunogenicity of revaccination with 23-valent pneumococcal polysaccharide vaccine between healthy elderly and those with diabetes in Korea
NCT03717194 / CompletedPhase 3IIT
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, to Evaluate the Effect of Ertugliflozin on Cardiac Function in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control and Stage B Heart Failure
100 Clinical Results associated with MSD Korea Co. Ltd.
Login to view more data
0 Patents (Medical) associated with MSD Korea Co. Ltd.
Login to view more data
100 Deals associated with MSD Korea Co. Ltd.
Login to view more data
100 Translational Medicine associated with MSD Korea Co. Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2 Clinical
2
1
Phase 3 Clinical
Approved
4
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free